Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.7 |
mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |